Electron paramagnetic resonance highlights that the oxygen effect contributes to the radiosensitizing effect of paclitaxel

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Danhier, Fabienne ^a   Danhier, Pierre ^a   Magotteaux, Nicolas ^a   de Preter, Géraldine ^a   Ucakar, Bernard ^a   Karroum, Oussama ^a   Jordan, Bénédicte ^a   Gallez, Bernard ^a   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MACROGOL; OXYGEN; PACLITAXEL; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER RADIOTHERAPY; DRUG EFFECT; ELECTRON SPIN RESONANCE; LIVER TUMOR; MALE; MICELLE; MOUSE; NICK END LABELING; NONHUMAN; OXIMETRY; OXYGEN CONSUMPTION; RADIATION DOSE; RADIOSENSITIZATION; TUMOR BLOOD FLOW; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; ELECTRON SPIN RESONANCE SPECTROSCOPY; IN SITU NICK-END LABELING; MALE; MICE; MICELLES; MODELS, BIOLOGICAL; NEOPLASMS; OXYGEN; OXYGEN CONSUMPTION; PACLITAXEL; PARTIAL PRESSURE; PERFUSION; RADIATION-SENSITIZING AGENTS; STAINING AND LABELING;

MUS;

EID: 84863741171     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040772     Document Type: Article

References (23)

1. Singla AK, Garg A, Aggarwal D, (2002) Paclitaxel and its formulations, Int. J. Pharm (235): 179-92.
2. Adams JD, Flora KP, Goldspiel BR, Wilson JW, Arbuck SG, et al. (1993) Taxol: a history of pharmaceutical development and current pharmaceutical concerns, J. Natl. Cancer Inst. Monogr pp. 141-47.
3. Milas L, Hunter N, Mason KA, Milross C, Peters LJ, (1995) Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse, Acta Oncol. 34: 409-412.
4. Tishler RB, Geard CR, Hall EJ, Schiff PB, (1992) Taxol sensitizes human astrocytoma cells to radiation, Cancer Res. 52: 3495-97.
5. Milas L, Hunter NR, Mason KA, Milross CG, Saito Y, et al. (1995) Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel, Cancer Res. 55: 3564-68.
6. Overgaard J, (2007) Hypoxic radiosensitization: adored and ignored. J. Clin. Oncol. 25: 4066-74.
7. Gallez B, Baudelet C, Jordan BF, (2004) Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications, NMR Biomed. 17: 240-62.
8. Vaupel P, Kelleher DK, Thews O, (1998) Modulation of tumor oxygenation, Int. J. Radiat. Oncol. Biol. Phys. 42: 843-48.
9. Danhier F, Magotteaux N, Ucakar B, Lecouturier N, Brewster M, et al. (2009) Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for Paclitaxel, Eur. J. Pharm. Biopharm. 73: 230-38.
10. Maeda H, (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting, Adv. Enzyme Regul (41): 189-207.
11. Danhier F, Feron O, Préat V, (2010) To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Rel. 148: 135-146.
12. Ould-Ouali L, Arien A, Rosenblatt J, Natan A, Twaddle T, et al. (2004) Biodegradable self-assembling PEG-copolymer as vehicle for poorly water-soluble drugs, Pharm. Res. 21: 1581-90.
13. Taper HS, Woolley GW, Teller MN, Lardis MP, (1966) A new transplantable mouse liver tumor of spontaneous origin, Cancer Res. 26: 143-48.
14. Gallez B, Jordan BF, Baudelet C, Misson PD (1999) Pharmacological modifications of the partial pressure of oxygen in murine tumors: evaluation using in vivo EPR oximetry, Magn Reson. Med. 42: 627-30.
15. Jordan BF, Misson P, Demeure R, Baudelet C, Beghein N, et al. (2000) Changes in tumor oxygenation/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI, Int. J. Radiat. Oncol. Biol. Phys. 48: 565-70.
16. Ansiaux R, Baudelet C, Jordan BF, Beghein N, Sonveaux P, et al. (2005) Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clin. Cancer Res. 11: 743-50.
17. Crokart N, Jordan BF, Baudelet C, Beghein N, Sonveaux P, et al. (2005) Early reoxygenation in tumors after irradiation: determining factors and consequences for radiotherapy regimens using daily multiple fractions, Int. J. Radiat. Oncol. Biol. Phys. 63: 901-10.
18. James PE, Jackson SK, Grinberg OY, Swartz HM, (1995) The effects of endotoxin on oxygen consumption of various cell types in vitro: an EPR oximetry study, Free Radic. Biol. Med. 18: 641-47.
19. Jordan BF, Sonveaux P, Feron O, Gregoire V, Beghein N, et al. (2003) Nitric oxide-mediated increase in tumor blood flow and oxygenation of tumors implanted in muscles stimulated by electric pulses, Int. J. Radiat. Oncol. Biol. Phys. 55: 1066-73.
20. Milross CG, Mason KA, Hunter NR, Terry NH, Patel N, et al (1997) Enhanced radioresponse of paclitaxel-sensitive and-resistant tumours in vivo, Eur. J. Cancer 33: 1299-308.
21. Ansiaux R, Baudelet C, Cron G, Segers J, Dessy C, et al. (2006) Botulinium toxin potentiates cancer radiotherapy and chemotherapy. Clin. Cancer Res. 12: 1276-83.
22. Diepart C, Karroum O, Magat J, Feron O, Verrax J, et al. (2012) Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors. Cancer Res. 72: 482-90.
23. Negishi T, Koizumi F, Uchino H, (2006) NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel. Brit. J. Cancer 95: 601-6.